Litcius/Paper detail

White adipose tissue dysfunction in obesity and aging

Marjorie Reyes‐Farias, Júlia Fos-Domènech, Dolors Serra, Laura Herrero, David Sánchez‐Infantes

2021Biochemical Pharmacology230 citationsDOIOpen Access PDF

Abstract

Both obesity and aging are associated with the development of metabolic diseases such as type 2 diabetes and cardiovascular disease. Chronic low-grade inflammation of adipose tissue is one of the mechanisms implicated in the progression of these diseases. Obesity and aging trigger adipose tissue alterations that ultimately lead to a pro-inflammatory phenotype of the adipose tissue-resident immune cells. Obesity and aging also share other features such as a higher visceral vs. subcutaneous adipose tissue ratio and a decreased lifespan. Here, we review the common characteristics of obesity and aging and the alterations in white adipose tissue and resident immune cells. We focus on the adipose tissue metabolic derangements in obesity and aging such as inflammation and adipose tissue remodeling.

Topics & Concepts

Adipose tissueWhite adipose tissueInflammationInternal medicineEndocrinologyAdipose tissue macrophagesObesityMedicineType 2 diabetesImmune systemDiabetes mellitusBiologyImmunologyAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismCardiovascular Disease and Adiposity
White adipose tissue dysfunction in obesity and aging | Litcius